跳至主要内容
临床试验/NCT05515341
NCT05515341已完成不适用

A DirEct to PatieNt Study in Chronic Pain

Boston Scientific Corporation1 个研究点 分布在 1 个国家目标入组 73 人开始时间: 2023年1月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
73
试验地点
1
主要终点
Change in pain post procedure

研究概览

简要总结

To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is planning to receive or has received a commercially approved interventional medical device therapy/procedure to treat chronic pain, ascertained from self-reporting
  • Age ≥ 22 years at time of eligibility screening, ascertained by self-reported age at time of eligibility screening
  • Proficient in written and spoken English, defined by self-reporting of comfort reading, writing and speaking English

排除标准

  • Requires a legal representative to sign the ICF ascertained from self-reporting

研究组 & 干预措施

Medical Device Therapy/Procedure for Chronic Pain

干预措施: Commercially Approved Interventional Medical Device/Therapy for Chronic Pain (Device)

结局指标

主要结局

Change in pain post procedure

时间窗: up to 12 months

Change in patient-reported pain on a scale of 0 - 10 where 0 is no pain and 10 is maximum pain

Targeted Pain Responder Rate

时间窗: up to 40 months post study enrollment

Percentage of subjects with a 50 percent or greater reduction in targeted pain intensity, based on self-reported percent pain relief

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A DirEct to PatieNt Study in Chronic Pain | 临床试验